Thailand - Delayed Quote THB

Bumrungrad Hospital Public Company Limited (BH.BK)

164.00
-1.00
(-0.61%)
At close: May 16 at 4:38:36 PM GMT+7
Loading Chart for BH.BK
  • Previous Close 165.00
  • Open 165.50
  • Bid --
  • Ask --
  • Day's Range 162.50 - 166.00
  • 52 Week Range 158.50 - 284.00
  • Volume 2,759,521
  • Avg. Volume 3,790,382
  • Market Cap (intraday) 130.374B
  • Beta (5Y Monthly) 0.05
  • PE Ratio (TTM) 18.89
  • EPS (TTM) 8.68
  • Earnings Date Jul 31, 2025
  • Forward Dividend & Yield 5.00 (3.05%)
  • Ex-Dividend Date Mar 19, 2025
  • 1y Target Est 220.43

Bumrungrad Hospital Public Company Limited owns and operates hospitals in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, paediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Further, the company offers clinical research, hospital consulting and management, healthcare personnel development and training, healthcare referral, and digital platform services. Additionally, it is involved in the distribution of pharmaceutical and medical goods in specialized stores; development of software for healthcare services; holding of real estate assets; and manufacture and sale of vitamin supplements. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.

www.bumrungrad.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BH.BK

View More

Performance Overview: BH.BK

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

BH.BK
16.40%
MSCI WORLD (^990100-USD-STRD)
3.88%

1-Year Return

BH.BK
33.55%
MSCI WORLD (^990100-USD-STRD)
11.26%

3-Year Return

BH.BK
1.29%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

BH.BK
62.88%
MSCI WORLD (^990100-USD-STRD)
92.36%

Compare To: BH.BK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BH.BK

View More

Valuation Measures

As of 5/16/2025
  • Market Cap

    130.37B

  • Enterprise Value

    116.53B

  • Trailing P/E

    18.92

  • Forward P/E

    17.36

  • PEG Ratio (5yr expected)

    3.69

  • Price/Sales (ttm)

    5.62

  • Price/Book (mrq)

    4.46

  • Enterprise Value/Revenue

    4.60

  • Enterprise Value/EBITDA

    11.44

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    29.50%

  • Return on Assets (ttm)

    16.93%

  • Return on Equity (ttm)

    27.22%

  • Revenue (ttm)

    25.5B

  • Net Income Avi to Common (ttm)

    7.52B

  • Diluted EPS (ttm)

    8.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.99B

  • Total Debt/Equity (mrq)

    0.48%

  • Levered Free Cash Flow (ttm)

    5.27B

Research Analysis: BH.BK

View More

People Also Watch